Averill Master Fund, Ltd.
SEC CIK 1939329 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | Dir, 10% | 7.90M | $416.6K | — | 2 | 2024-09-26 | 2024-11-19 |
Most active insiders at BNTC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | $20.00M | — |
| 2 | Cowen Aaron | Dir, 10% | $1.90M | — |
| 3 | Averill Madison Master Fund, Ltd. | 10% | $539.0K | — |
| 4 | BUCHI J KEVIN | Dir | — | — |
Averill Master Fund, Ltd. made no open-market trades at BNTC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-21 | 2024-11-19+ | BNTC | Benitec Biopharma Inc. | Averill Master Fund, Ltd. | Dir, 10% | P - Purchase | $10.05 | +41.4K | 7.90M | +0.5% | +$416.6K |
| DMI | 2024-09-30 | 2024-09-26 | BNTC | Benitec Biopharma Inc. | Averill Master Fund, Ltd. | Dir, 10% | X - OptEx | $2.96 | +7.14M | 6.66M | New | +$21.14M |
Purchase Sale Sale after option exercise All abbreviations